{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/721-US20210060002A1(Pending) not sealed.pdf"}, "page_content": "Berbamine\n\nSRN ASDAPI\n\nFig. 3A\n\nAIRE DAPI\n\nMock Berbamine omn \u52a0 40 min\n\nFig. 3B\n\nTime after infection\n\nPatent Application Publication\n\nMar. 4 , 2021 Sheet 8 of 16\n\nUS 2021/0060002 A1\n\n10.99\n\nFig . 4A\n\n:\n\nFig . 4B\n\nRelatvie\n\ninfectivity ( % )\n\n2\n\nlog [ Isotetrandrinel , M\n\nFig . 40\n\nMar. 4, 2021 Sheet 8 of 16\n\nUS 2021/0060002 Al\n\nPatent Application Publication\n\n38 h after JEV infection \u591a\n\nFig. 4A\n\n18 h afier Ziv infection\n\nR=8 9833 Relatvie infectivity (%)} \u548c 2 3 4 \u00a7\n\nFig. 4C\n\nECgy1 2. taM\n\nlog [faoteteandrinc], aM\n\nPatent Application Publication\n\nMar. 4 , 2021 Sheet 9 of 16\n\nUS 2021/0060002 A1\n\nSuska\n\nFig . 5A\n\nFig . 5B\n\nRelaxie\n\ninfectivity ( )\n\nSO\n\n3\n\n1\n\nlog | Fangchinolinel , aM\n\nFig . 5C\n\nMar. 4, 2021 Sheet 9 of 16\n\nUS 2021/0060002 Al\n\nPatent Application Publication\n\n18 h after JEV infection |\n\nFig. 5A\n\nRelatvie infectivity (%} i 2 3 4 5 log|Fangchieeliae|, aft\n\nFig. 5C\n\n18 h alter ZIRV infection\n\nPatent Application Publication\n\nMar. 4 , 2021 Sheet 10 of 16 US 2021/0060002 A1\n\nAPDHI\n\nGAPDH\n\nFig . 6A\n\nOMSO\n\n2\n\nus\n\nDsRNA staining DAPI staining\n\nFig . 68\n\nMar. 4, 2021 Sheet 10 of 16\n\n\u201cUS 2021/0060002 Al\n\nPatent Application Publication\n\nFig. BA\n\n18 h after Virus infection\n\nDMSO 20 ub barbainine 43 UM berbarming\n\nfangchincline 20 uM fengchinoline 16 uM isoletrandrine 40-uM isotetrandring\n\nDSRNA staining DAP! staining\n\nFig. 6B\n\n1G uM\n\nPatent Application Publication\n\nMar , 4 , 2021 Sheet il of 16\n\nUS 2021/0060002 Ai\n\n24 h after DENV infection\n\nSuljoviyobue :\n\nIsotetrandrine\n\nFig . 7A\n\nRelatvie\n\nInfectivity ( % )\n\nDMSO Bertamine Fangchinoline Isotetrandrine\n\n5 15 30 10 20 30\n\nFig . 7B\n\nMar. 4, 2021 Sheet 11 of 16\n\nUS 2021/0060002 Al1\n\nPatent Application Publication\n\n24 h after DENV infection\n\nBerbarnine isotetrandiine\n\nBs RNA staining DAP staining\n\nFig. 7A\n\n\u516d \u8fd9 8 8 Raelatvie infectivity (%} 2 o \u00a7 18 30 10 20 20 19 20 40 of @ & oe gv or Be Oh cot gd gh\n\nFangchingline\n\nabun\n\nye\n\neS\n\nSO\n\nPatent Application Publication\n\nMar. 4 , 2021 Sheet 12 of 16 US 2021/0060002 A1", "type": "Document"}}